SenesTech Inc (NASDAQ: SNES) is a pest control company that develops and sells fertility control products for rodent population management. Revenue comes from direct product sales, with two commercial offerings: Evolve, a newer bait product launched in January 2024, and ContraPest, the original product. Evolve represented 81% of net sales in FY2025 and ContraPest represented 19%, together generating $2.2 million in net revenue for the year ended December 31, 2025. Gross profit margin improved to 62.5% in FY2025 from 54.1% in FY2024, driven by the shift toward Evolve, which carries higher margins. The company operates at a significant loss, with a net loss of $6.4 million in FY2025 against $2.2 million in net revenue. SenesTech manufactures its products at a 17,000 square foot facility in Surprise, Arizona, leased through May 2035. Joel Fruendt serves as President and CEO, with Thomas C. Chesterman as CFO as of the filing date of March 13, 2026.

Revenue model

Transactional product sales of rodent fertility control baits. Products are sold through distributors, who receive lower per-unit pricing due to volume, and through direct channels. No subscription or royalty model is disclosed in the filing excerpts.

Products and services

Evolve: rodent fertility control bait product launched January 2024, representing 81% of net revenue ($1.8 million) in FY2025. ContraPest: original rodent fertility control product, representing 19% of net revenue ($412,000) in FY2025.

Customers and end markets

Pest control end market focused on rodent population management. Products sold through distributors and direct channels. No specific customer concentration data or named customers are disclosed in the filing excerpts.

Value-chain role

Product manufacturer and seller. SenesTech manufactures its fertility control bait products at its Surprise, Arizona facility and sells through distributors as well as direct channels.

Geographic exposure

Operations based in Surprise, Arizona as of December 31, 2025. No international revenue breakdown or geographic segment data is disclosed in the filing excerpts.

Source: SEC 10-K, filed 2026-03-13

Industry: Agricultural Chemicals Peers: Avenue Therapeutics Inc Dermata Therapeutics Inc Grapefruit USA, Inc NEXIEN BIOPHARMA, INC. Johnson & Johnson Stablecoin Development Corp Stem Holdings, Inc.